Immunogenic composition
US9409974B2 · kind B2 · utility
3Cited by
0References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 25, 2012 |
| Grant date | Aug 9, 2016 |
| Priority date | — |
| Expiry date | May 25, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to fusion proteins comprising fragments from toxin A and/or toxin B of Clostridium difficile, wherein the polypeptide elicits antibodies that neutralize toxin A or toxin B or both.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.